Timothy Hoey
Chief Tech/Sci/R&D Officer chez TENAYA THERAPEUTICS, INC.
Fortune : 1 M $ au 31/03/2024
Profil
Dr. Timothy Hoey is a Chief Scientific Officer at Tenaya Therapeutics, Inc. Dr. Hoey was previously employed as a Co-Chief Scientific Officer & SVP-Cancer Biology by OncoMed Pharmaceuticals, Inc., a Director-Biology Department by Amgen, Inc., and a Director-Biology Department by Tularik, Inc. He received his undergraduate degree from the University of Michigan and a doctorate degree from The Trustees of Columbia University in The City of New York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/03/2024 | 245 346 ( 0,31% ) | 1 M $ | 31/03/2024 |
Postes actifs de Timothy Hoey
| Sociétés | Poste | Début |
|---|---|---|
| TENAYA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2017 |
Anciens postes connus de Timothy Hoey
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01/01/2017 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2005 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Director/Board Member | 14/12/2011 |
Formation de Timothy Hoey
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | Commercial Services |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
| Tenaya Therapeutics, Inc. |
